US5120840AExpiredUtilityPatentIndex 73
4-amino-4-ene-steroids and their use as 5α-reductase inhibitors
Est. expiryAug 1, 2010(expired)· nominal 20-yr term from priority
C07J 41/0027C07J 41/0011C07J 41/0005
73
PatentIndex Score
9
Cited by
11
References
9
Claims
Abstract
The present invention relates to 4-amino-Δ 4 -steroids which are useful as inhibitors of 5α-reductase. The compounds are prepared by the reaction of an appropriate 4-azido steroid with triphenylphosphine in an aqueous inert solvent with heating. The present application is a continuation-in-part of application Ser. No. 561,041, filed Aug. 1, 1990 and application Ser. No. 671,555, filed Mar. 19, 1991.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A compound of the formula: ##STR9## wherein R is hydrogen or C 1-4 alkyl; R 1 is C 2-6 alkanoyl, --(C 1-6 alkyl)-OZ 2 , --(C 2-6 alkyl)--(OZ 2 ) 2 or --A--C(O)--Y; Z 2 is hydrogen, C 1-6 alkyl, phenyl-(C 1-4 alkyl), (Y 1 -substituted phenyl)-(C 1-4 alkyl), C 1-6 alkanoyl, benzoyl or Y 1 -substituted benzoyl wherein Y 1 is methyl, halogen or methoxy; A is absent or is present as an alkylene of 1 to 6 carbon atoms; Y is --OH, --O(C 1-6 alkyl) or --NR 3 R 4 ; R 2 is hydrogen or R 1 and R 2 can be combined to give --O--CH 2 CH 2 CH 2 ---; R 3 and R 4 are each independently hydrogen, C 1-6 alkyl, C 3-6 cycloalkyl or they can be combined to give --(CH 2 ) n --wherein n is 4 to 6; R 5 is hydrogen or methyl; X is O or (H)(H); Z is hydrogen or C 1-6 alkyl; Z 1 is hydrogen or methylene; and each of the dotted lines in the rings indicates the optional presence of a double bond with the proviso that a 9,11-double bond can only be present when X is (H)(H) and the proviso that, when a 16,17-double bond is present, then R 2 is absent.
2. A compound according to claim 1 which has the formula: ##STR10## wherein R is hydrogen or C 1-4 alkyl; R 1 is C 2-6 alkanoyl, --CH(CH 3 )--CH 2 OZ 2 , --CH(CH 3 )--COO(C 1-6 alkyl) or --C(O)--NR 3 R 4 ; R 2 is hydrogen or R 1 and R 2 can be combined to give --O--CH 2 CH 2 CH 2 ---; Z 2 is hydrogen, C 1-6 -alkyl or C 1-6 alkanoyl; R 3 and R 4 are each independently hydrogen, C 1-6 alkyl, C 3-6 cycloalkyl or they can be combined to give --(CH 2 ) n --wherein n is 4 to 6.
3. A compound according to claim 2 which has the formula: ##STR11## wherein R is hydrogen or C 1-4 alkyl; R 3 and R 4 are each independently hydrogen, C 1-6 alkyl, C 3-6 cycloalkyl or they can be combined to give --(CH 2 ) n --wherein n is 4 to 6.
4. A compound according to claim 3 which has the formula: ##STR12## wherein R 3 and R 4 are each independently hydrogen or C 1-6 alkyl
5. A compound according to claim 4 which is 4-amino-N-(1,1-dimethylethyl)-3-oxoandrost-4-ene-17β-carboxamide
6. A compound according to claim 4 which is 4-amino-N,N-bis(1-methylethyl)-3-oxoandrost-4-ene-17β-carboxamide.
7. A compound according to claim 1 which has the formula: ##STR13## wherein R is hydrogen or C 1-4 alkyl; R 1 is --(C 1-6 alkyl)-OZ 2 or --(C 2-6 alkyl)--(OZ 2 ) 2 ; Z 2 is hydrogen, C 1-6 alkyl, phenyl-(C 1-4 alkyl), (Y 1 -substituted phenyl)-(C 1-4 alkyl), C 1-6 alkanoyl, benzoyl or Y 1 -substituted benzoyl wherein Y 1 is methyl, halogen or methoxy; R 5 is hydrogen or methyl; X is O or (H)(H); Z is hydrogen or C 1-6 alkyl; Z 1 is hydrogen or methylene; and each of the dotted lines in the rings indicates the optional presence of a double bond with the proviso that a 9,11-double bond can only be present when X is (H)(H).
8. A compound according to claim 7 which has the formula: ##STR14## wherein Z 2 is hydrogen, C 1-6 alkyl, phenyl-(C 1-4 alkyl), (Y 1 -substituted phenyl)-(C 1-4 alkyl), C 1-6 alkanoyl, benzoyl or Y 1 -substituted benzoyl wherein Y 1 is methyl, halogen or methoxy; R 5 is hydrogen Or methyl; Z is hydrogen or C 1-6 alkyl; Z 1 is hydrogen or methylene; and each of the dotted lines in the rings indicates the optional presence of a double bond.
9. A compound according to claim 7 which is (20S)-4-amino-21-hydroxy-20-methylpregn-4-en-3-one.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.